Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China


The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of insulin, focusing on serving local diabetic patients.

https://www.profitablecpmrate.com/s4wynci74?key=f3321622cc023173449e145c2ac0fa08

Leave a Comment